Risk Algorithm Using Serial Biomarker Measurements Doubles Number of Screen-Detected Ovarian Cancers Compared With a Single-Threshold Rule
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening
J. Clin. Oncol 2015 May 11;[EPub Ahead of Print], U Menon, A Ryan, J Kalsi, A Gentry-Maharaj, A Dawnay, M Habib, S Apostolidou, N Singh, E Benjamin, M Burnell, S Davies, A Sharma, R Gunu, K Godfrey, A Lopes, D Oram, J Herod, K Williamson, MW Seif, H Jenkins, T Mould, R Woolas, JB Murdoch, S Dobbs, NN Amso, S Leeson, D Cruickshank, I Scott, L Fallowfield, M Widschwendter, K Reynolds, A McGuire, S Campbell, M Parmar, SJ Skates, I JacobsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.